David L. Rosenband
David L. Rosenband is an associate attorney at the New York City based personal injury law firm of Weitz & Luxenberg.
Part of Weitz & Luxenberg's Drug and Medical Device Litigation group since 2001, his mission is to obtain justice on behalf of individuals who innocently placed their trust in a supposedly safe drug or medical device, only to end up suffering a debilitating or life-threatening injury — or, worse, passing along the injury in the form of a birth defect to an offspring.
Mass-tort litigations in which Mr. Rosenband has been involved include Fen-Phen, Rezulin, Baycol, Guidant defibrillators, Medtronic Sprint Fidelis leads, Zyprexa, Seroquel, Vioxx, Bextra, Celebrex, ReNu with MoistureLoc, Zimmer NexGen Knee, Accutane, and Actos.
He was appointed to act as co-plaintiff liaison counsel in the New York Bextra and Celebrex product liability litigation and, in 2012, he was a member of the trial team responsible for securing a $9-million verdict on behalf of a former Accutane user (who subsequently was diagnosed with ulcerative colitis and forced to undergo numerous operations culminating in removal of her colon).
Notable Court Victories
|Amount||Case||Case Type||Victory Type|
|$18,000,000||Rossitto, et al. v. Hoffmann-La Roche Inc.||Personal Injury; Defective Drugs; Product Liability||Verdict|
Membership in Court Victories Clubs
Multimillion-Dollar Verdicts & Settlements Club - member since 2017.
Weitz & Luxenberg PC
New York, NY 10003
Phone: (212) 558-5500